Get startedLog in
    Picture of Hofseth Biocare ASA logo

    HBCo — Hofseth Biocare ASA Income Statement

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeSmall CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Hofseth Biocare ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue69.387.6120195257
    Cost of Revenue
    Gross Profit13.72.5128.544.287.9
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses161206249297362
    Operating Profit-92-119-129-103-105
    Total Net Non Operating Interest Income / Expense
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-102-126-137-107-125
    Provision for Income Taxes
    Net Income After Taxes-102-126-137-107-125
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-102-126-137-107-125
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-102-126-137-107-125
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.3-0.347-0.363-0.331-0.321